Finance

Lists
Why is INM up 19,65%?
Dive Deeper
INM:NASDAQ
InMed Pharmaceuticals Inc
15,56 US$
+19,65%
(+2,56) 1D
6 ნოე, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INM...
Open
13,71 US$
High
16,44 US$
Low
13,70 US$
Mkt. cap
8,55 მლნ.
Avg. vol.
7,20 ათ.
Volume
27,15 ათ.
52-wk high
23,30 US$
52-wk low
5,75 US$
EPS
-2,73 US$
Beta
0,94
Shares outstanding
549,00 ათ.
No. of employees
6
Open
13,71 US$
High
16,44 US$
Low
13,70 US$
Mkt. cap
8,55 მლნ.
Avg. vol.
7,20 ათ.
Volume
27,15 ათ.
52-wk high
23,30 US$
52-wk low
5,75 US$
EPS
-2,73 US$
Beta
0,94
Shares outstanding
549,00 ათ.
No. of employees
6
News stories
From web sources and news partners
About InMed Pharmaceuticals Inc
CEOერიკ ეი ადამს
Employees6
Founded1981
Headquartersვანკუვერი, ბრიტანეთის კოლუმბია, კანადა
SectorHealth Care
IndustryPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
820,19 ათ.
-
-
-
Cost of goods sold
635,99 ათ.
-
-
-
Cost of revenue
635,99 ათ.
-
-
-
Research and development expenses
630,64 ათ.
1,02 მლნ.
805,74 ათ.
206,02 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,62 მლნ.
1,74 მლნ.
2,36 მლნ.
1,80 მლნ.
Operating expense
2,30 მლნ.
2,82 მლნ.
3,21 მლნ.
2,01 მლნ.
Total operating expenses
2,94 მლნ.
2,82 მლნ.
3,21 მლნ.
2,01 მლნ.
Operating income
-2,12 მლნ.
-2,82 მლნ.
-3,21 მლნ.
-2,01 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-2,03 მლნ.
-2,79 მლნ.
-4,84 მლნ.
-2,00 მლნ.
EBT excluding unusual items
-2,03 მლნ.
-2,79 მლნ.
-3,19 მლნ.
-2,00 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,03 მლნ.
-2,97 მლნ.
-5,84 მლნ.
-2,33 მლნ.
Net profit margin
-247,29%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
74,38 ათ.
47,77 ათ.
29,06 ათ.
14,31 ათ.
Interest expense
-
-
-10,70 ათ.
-
Net interest expenses
74,38 ათ.
47,77 ათ.
18,36 ათ.
14,31 ათ.
Depreciation and amortization charges
53,20 ათ.
51,71 ათ.
48,36 ათ.
168,00
EBITDA
-2,07 მლნ.
-2,77 მლნ.
-3,16 მლნ.
-2,01 მლნ.
Gain or loss from assets sale
-
-
7,14 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები